These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33722736)

  • 1. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets.
    Tuli HS; Aggarwal V; Tuorkey M; Aggarwal D; Parashar NC; Varol M; Savla R; Kaur G; Mittal S; Sak K
    Toxicol In Vitro; 2021 Jun; 73():105142. PubMed ID: 33722736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review).
    Wei WT; Lin SZ; Liu DL; Wang ZH
    Oncol Rep; 2013 Dec; 30(6):2555-62. PubMed ID: 24065213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of natural anthraquinone emodin: an assessment in mice.
    Sougiannis AT; Enos RT; VanderVeen BN; Velazquez KT; Kelly B; McDonald S; Cotham W; Chatzistamou I; Nagarkatti M; Fan D; Murphy EA
    BMC Pharmacol Toxicol; 2021 Jan; 22(1):9. PubMed ID: 33509280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.
    Liu H; Gao M; Xu H; Guan X; Lv L; Deng S; Zhang C; Tian Y
    Pharm Res; 2016 Jan; 33(1):217-36. PubMed ID: 26334502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer.
    Bhattacharjee M; Upadhyay P; Sarker S; Basu A; Das S; Ghosh A; Ghosh S; Adhikary A
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129695. PubMed ID: 32735937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
    Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
    Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
    Kim YS; Lee YM; Oh TI; Shin DH; Kim GH; Kan SY; Kang H; Kim JH; Kim BM; Yim WJ; Lim JH
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of emodin on gynecological cancer cells.
    Wang Y; Yu H; Zhang J; Ge X; Gao J; Zhang Y; Lou G
    Cell Oncol (Dordr); 2015 Oct; 38(5):353-63. PubMed ID: 26162964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
    BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antineoplastic effects of Aloe-emodin: a comprehensive review.
    Chen R; Zhang J; Hu Y; Wang S; Chen M; Wang Y
    Am J Chin Med; 2014; 42(2):275-88. PubMed ID: 24707862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
    Lin SZ; Wei WT; Chen H; Chen KJ; Tong HF; Wang ZH; Ni ZL; Liu HB; Guo HC; Liu DL
    PLoS One; 2012; 7(8):e42146. PubMed ID: 22876305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on their Cell Cycle Arrest, Apoptosis Pathway and Migration.
    Yang K; Jin MJ; Quan ZS; Piao HR
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30832378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Hintzpeter J; Seliger JM; Hofman J; Martin HJ; Wsol V; Maser E
    Toxicol Appl Pharmacol; 2016 Feb; 293():21-9. PubMed ID: 26773812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of lung-targeting, emodin-loaded polylactic acid microspheres and their properties.
    Chen X; Yang Z; Sun R; Mo Z; Jin G; Wei F; Hu J; Guan W; Zhong N
    Int J Mol Sci; 2014 Apr; 15(4):6241-51. PubMed ID: 24733070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.
    Wang T; Yin X; Lu Y; Shan W; Xiong S
    Int J Nanomedicine; 2012; 7():2325-37. PubMed ID: 22661889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.
    Li XX; Dong Y; Wang W; Wang HL; Chen YY; Shi GY; Yi J; Wang J
    Stem Cells Dev; 2013 Feb; 22(4):554-66. PubMed ID: 22974371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxicity of aconitine, emodin on ICC cell and the antagonist effect of the compatibility.
    Peng C; Wang L; Wang YH; Li YX; Pan Y
    Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):213-20. PubMed ID: 20166441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.